XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Changes in Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Total
Beginning balance at Dec. 31, 2023 $ 291 $ 409,980 $ (376,081)   $ 34,190
Beginning balance, shares at Dec. 31, 2023 29,092        
Share-based awards and options exercises $ 9 (9)      
Share-based awards and options exercises (in shares) 883        
Share-based compensation expense   1,338     1,338
Net income (loss)     (7,873)   (7,873)
Ending balance at Mar. 31, 2024 $ 300 411,309 (383,954)   27,655
Ending balance, shares at Mar. 31, 2024 29,975        
Beginning balance at Dec. 31, 2023 $ 291 409,980 (376,081)   34,190
Beginning balance, shares at Dec. 31, 2023 29,092        
Net income (loss)         (31,046)
Ending balance at Sep. 30, 2024 $ 303 416,205 (407,127)   9,381
Ending balance, shares at Sep. 30, 2024 30,317        
Beginning balance at Mar. 31, 2024 $ 300 411,309 (383,954)   27,655
Beginning balance, shares at Mar. 31, 2024 29,975        
Share-based awards and options exercises $ 1 (1)      
Share-based awards and options exercises (in shares) 161        
Share-based compensation expense   1,563     1,563
Net income (loss)     (9,832)   (9,832)
Ending balance at Jun. 30, 2024 $ 301 412,871 (393,786)   19,386
Ending balance, shares at Jun. 30, 2024 30,136        
Share-based awards and options exercises $ 2 (2)      
Share-based awards and options exercises (in shares) 181        
Issuance of warrants, net of issuance cost of $35   1,917     1,917
Share-based compensation expense   1,419     1,419
Net income (loss)     (13,341)   (13,341)
Ending balance at Sep. 30, 2024 $ 303 416,205 (407,127)   9,381
Ending balance, shares at Sep. 30, 2024 30,317        
Beginning balance at Dec. 31, 2024 $ 557 446,938 (419,789) $ 4,093 31,799
Beginning balance, shares at Dec. 31, 2024 55,679        
Share-based awards and options exercises $ 9 (1)     8
Share-based awards and options exercises (in shares) 941        
Issuance of common stock, net of issuance costs $ 92 18,877     18,969
Issuance of common stock, net of issuance costs (in shares) 9,200        
Share-based compensation expense   1,444     1,444
Net income (loss)     (12,675) (14) (12,689)
Ending balance at Mar. 31, 2025 $ 658 467,258 (432,464) 4,079 39,531
Ending balance, shares at Mar. 31, 2025 65,820        
Beginning balance at Dec. 31, 2024 $ 557 446,938 (419,789) 4,093 31,799
Beginning balance, shares at Dec. 31, 2024 55,679        
Net income (loss)         (31,929)
Ending balance at Sep. 30, 2025 $ 685 478,300 (451,629) 4,004 31,360
Ending balance, shares at Sep. 30, 2025 68,445        
Beginning balance at Mar. 31, 2025 $ 658 467,258 (432,464) 4,079 39,531
Beginning balance, shares at Mar. 31, 2025 65,820        
Share-based awards and options exercises $ 3 (2)     1
Share-based awards and options exercises (in shares) 293        
Share-based compensation expense   1,814     1,814
Net income (loss)     (10,120) 281 (9,839)
Ending balance at Jun. 30, 2025 $ 661 469,070 (442,584) 4,360 31,507
Ending balance, shares at Jun. 30, 2025 66,113        
Share-based awards and options exercises $ 1 3     4
Share-based awards and options exercises (in shares) 70        
Issuance of common stock, net of issuance costs $ 23 7,818     7,841
Issuance of common stock, net of issuance costs (in shares) 2,262        
Share-based compensation expense   1,409     1,409
Net income (loss)     (9,045) (356) (9,401)
Ending balance at Sep. 30, 2025 $ 685 $ 478,300 $ (451,629) $ 4,004 $ 31,360
Ending balance, shares at Sep. 30, 2025 68,445